Qiming, TF Capital Lead $10M Series A In CANbridge Life Sciences
December 4, 2014 — 14:50 CST
This Data Is Locked!
This area is available only to Subscribers.
Beijing-based bio-pharmaceutical company CANbridge Life Sciences Ltd. has completed US$10 million series A financing from Qiming Venture Partners and TF Capital, a venture fund started... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals
